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Polycystic ovary syndrome (PCOS) is a frequent disorder, affecting approximately
5–10% of infertile women. It can represent more than 80% of cases of infertility due to
anovulation. The main goal of treatment is the induction of mono-ovulatory cycles. A
pragmatic management of infertility in PCOS will allow most patients to conceive. Weight
loss and clomiphene citrate (CC) are the first-line components of patients treatment
before gonadotrophins are used. However, during gonadotrophin administration, there
is a high risk of ovarian hyper-stimulation and multiple pregnancies. So, surgery with
laparoscopic ovarian drilling is often used before gonadotrophins in order to obtain
normal ovulatory cycles.
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Polycystic ovary syndrome (PCOS) is a frequent disorder, affecting 5–10% of infertile women (1, 2).
It is responsible for more than 80% of cases of infertility due to anovulation (3).
The main goal of treatment is the induction of mono-ovulatory cycles.
A “stepwise approach” to the management of infertility in PCOS will permit most patients to
achieve pregnancy and a live birth (4):
1. Appropriate living style, such as diet and physical exercises in order to reduce weight.
2. Oral medication agents:
 The first-line oral agents include clomiphene citrate (CC) (selective estrogen receptor
modulators) with 49% of ovulation rate, 30% of pregnancy rate, and 23% of live birth rate at
6months. Therefore, there is an increased rate of multiple gestation: 8%.
 The other first-line oral agent is Letrozole (aromatase inhibitors) with recent evidence
recommending the use of letrozole [in Ref. (4)]:
– the ovulation rate is 61.7% for letrozole versus 48.3% for CC, p< 0.0001;
– the live birth rate is 27.5% for letrozole versus 19.2% for CC, p= 0.007;
– there is 44% higher live birth rate with letrozole in patients with high body mass index
(BMI) and longstanding infertility.
 Metformin (insulin sensitizers) is an adjunct to induction of ovulation in patients with
glucose intolerance and obesity.
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For women with WHO Group II ovulation disorders who are
known to be resistant to CC, both the agency for Health-
care Research and Quality (AHRQ) and the National Institute
for Health and Clinical Excellence (NICE) consider one of
the following second-line treatments, depending on clinical
circumstances and the woman’s preference:
 laparoscopic ovarian drilling (LOD),
 combined treatment with CC and metformin if not already
offered as first-line treatment, or
 Gonadotrophins (5, 6).
3. Gonadotrophins are the second-line treatment in case of CC
resistance or CC failure (no pregnancy after four to six ovula-
tory cycles) (5, 7)
4. The LOD may be considered as a second-line treatment in a
selected population (3, 4). LOD may be considered in women
with CC-resistant PCOS, particularly when there are other
indications for laparoscopy, if there is a high risk of multi-
ple pregnancies or a contra-indication of multiple pregnan-
cies. (5, 7).
5. In vitro fertilization (IVF) is indicated in the treatment of
PCOS-associated infertility with high success rates and poten-
tially lower rate of multiple gestations if it is well managed.
Indeed, careful monitoring of controlled ovulation aims to
avoid multiple pregnancies when using gonadotrophins in
IVF (4).
In summary, weight loss and CC are the first-line components
of patients’ treatment before gonadotrophins use (5–7). How-
ever, during gonadotrophin administration, there is a high risk
of ovarian hyper-stimulation (OHSS) and multiple pregnancies.
The risk of multiple pregnancies after LOD is lower than for
gonadotrophin stimulation (4). So, surgery with LOD may be
an alternative before gonadotrophins in order to obtain normal
ovulatory cycles (5, 7).
Almost three decades after the first report of LOD using a
unipolar electrode by Halvard Gjönnaess (2), it was proposed as
a less invasive alternative than bilateral ovarian wedge resection;
till now, many controversies are still not clarified concerning
ovarian drilling mechanism of action and what is the best and
cost-effective technique in the treatment of PCOS syndrome.
The most plausible mechanisms of action are the destruction
of ovarian follicles and a part of the ovarian stroma, inducing a
reduction of serum androgens and inhibin levels, which results
in an increase of FSH and restores the ovulation function (1).
LOD may also increase ovarian blood flow, allowing a high deliv-
ery of gonadotrophins and post-surgical local growth factors.
An improvement of insulin sensitivity after LOD has also been
suggested (1, 4, 8, 9).
The common technique of LOD is the use of monopolar elec-
trocautery (diathermy) or laser with comparable results (8–12).
Normally, three to eight diathermy punctures are performed
in each ovary using 600–800 J energy for each puncture, lead
to further normal ovulation in 74% of the cases in the next
3–6months. More than eight punctures seem to increase the
occurrence of post-operative pelvic adhesions and decrease the
ovarian reserve (8).
Different other minimally invasive techniques were later
described for ovarian drilling. Some authors proposed LOD using
a bipolar energy probe as a potentially safer method compared to
unipolar energy. Other authors described the micro-laparoscopic
ovarian drilling technique (MLOD) under local anesthesia, which
allows outpatient management without general anesthesia (13).
Fertiloscopy (transvaginal hydrolaparoscopy) was also
described as a technique with comparable results to those of
laparoscopy (14).
Laser was also tested in laparoscopy or fertiloscopy for ovarian
drilling with the same results as monopolar needle.
A systematic Cochrane review including 25 randomized con-
trolled trials of sub-fertile women with clomiphene-resistant
PCOS who undertook LOD in order to induce ovulation con-
cluded that there was no evidence of a significant difference
in rates of clinical pregnancy, live birth, or miscarriage in
clomiphene-resistant PCOS women undergoing LOD compared
to other medical treatments.
The reduction of multiple pregnancy rates in women undergo-
ing LOD makes this technique attractive and useful (8).
In a comprehensive review of ovarian drilling for PCOS, Fer-
nandez (15) concluded that ovarian drilling leads to spontaneous
restoration of fertility in 20–64% of women with PCOS who
had previously been infertile as a result of anovulation and who
did not respond to CC treatment, while the meta-analysis by
Campo (16) reported a narrower range of success in 44–50% of
patients. Several factors could influence the efficacy of ovarian
drilling: a higher likelihood of success in patients with elevated
LH concentrations (>10 IU/l) and <3 years of infertility. However,
the influence of other factors, such as BMI, insulin resistance, and
testosterone concentrations, is contradictory (15, 17).
The results of LOD are not superior to CC as a first-line treat-
ment of ovulation induction in women with PCOS. Furthermore,
there is no significant difference in pregnancy and live birth rates
per women undergoing LOD versus six cycles of CC as a first-
line approach for anovulatory infertile patients. But, in women
with failure to conceive after six to nine cycles of CC, LOD is the
best choice to induce mono-ovulatory cycles with higher preg-
nancy rate. The mechanism is that LOD avoids peripheral anti-
estrogenic effects of CC on both endometrium and cervicalmucus
and the hypersecretion of LH leading to premature luteinization
in response to CC responsible for its failure (1, 18, 19).
Several studies have reported that LOD prior to ART is benefi-
cial in decreasing the risk of severe OHSS and increasing the “take
home baby “ rate in womenwho have previously had canceled IVF
cycles due to OHSS risk or who suffered fromOHSS in a previous
treatment. This finding may be attributed to a reduced ovarian
blood flow velocity and serum vascular endothelial growth factor
(VEGF) concentration after LOD (9).
In conclusion, all meta-analysis confirmed that LOD is a
second-line treatment in PCOS patients, especially those with CC
resistance (8, 9). The main benefits are shorter time to pregnancy
and less need to ovulation induction drugs. The other advan-
tages of this technique are more comfort, cost-effectiveness, and
possibility to be performed ambulatory.
However, the results of LOD are not better than those of CC as
a first-line treatment in PCOS.
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